Our analysis shows that an increased expression of CCL2 in MEDU is causally related with MS (OR = 1.31; 95% CI [1.12;1.54]), consistent with the above described results, and also ascribing a causative role to CCL2 expression, rather than a simple association with MS. The gene discussed is CCL2; the disease is myeloid sarcoma.